from Today's Healthcare News -- ScienceDaily http://ift.tt/1IFPB5A
Our mission is to advice, and to make the people of the world healthier through the power of information.
Clinical validation for LOXO-101 against TRK fusion cancer
The first imaging studies of TRK fusion cancer conducted post-treatment have confirmed that stage IV patient's tumors had substantially regressed. With four months of treatment, additional CT scans have demonstrated almost complete disappearance of the largest tumors.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1IFPB5A
from Today's Healthcare News -- ScienceDaily http://ift.tt/1IFPB5A
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment